Short Interest in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Declines By 27.1%

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a large decline in short interest in the month of February. As of February 27th, there was short interest totaling 2,586 shares, a decline of 27.1% from the February 12th total of 3,548 shares. Based on an average trading volume of 5,278 shares, the short-interest ratio is presently 0.5 days. Approximately 0.1% of the company’s stock are sold short. Approximately 0.1% of the company’s stock are sold short. Based on an average trading volume of 5,278 shares, the short-interest ratio is presently 0.5 days.

Institutional Trading of Fidelity Disruptive Medicine ETF

Several large investors have recently made changes to their positions in FMED. Jane Street Group LLC grew its stake in Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after acquiring an additional 44,630 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in shares of Fidelity Disruptive Medicine ETF by 4.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock worth $19,712,000 after acquiring an additional 31,629 shares in the last quarter. BXM Wealth LLC acquired a new stake in shares of Fidelity Disruptive Medicine ETF in the 4th quarter worth about $243,000. Vise Technologies Inc. acquired a new stake in shares of Fidelity Disruptive Medicine ETF in the 4th quarter worth about $234,000. Finally, Virtu Financial LLC bought a new position in Fidelity Disruptive Medicine ETF in the 4th quarter valued at about $228,000.

Fidelity Disruptive Medicine ETF Trading Down 1.3%

NASDAQ FMED traded down $0.32 on Friday, hitting $24.06. 5,860 shares of the company were exchanged, compared to its average volume of 8,038. The company has a market cap of $55.34 million, a PE ratio of 41.33 and a beta of 1.00. The stock has a fifty day moving average of $26.43 and a 200-day moving average of $26.37. Fidelity Disruptive Medicine ETF has a 12 month low of $20.69 and a 12 month high of $29.07.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.